Sustainability | January 07, 2026
WuXi Biologics secures ISO 20400 certification
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,
Pravesh brings with him over 29 years of experience in leading complex manufacturing operations and driving operational excellence
The approval introduces a needle-free alternative to injectable GLP-1 therapies
The company is pursuing the accelerated FDA 505(b)(2) approval pathway for its once-daily oral ondansetron formulation
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
Pembrolizumab has shown meaningful benefit only when combined with chemotherapy
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline
Subscribe To Our Newsletter & Stay Updated
